# SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas

> **NCT06544720** · PHASE1 · RECRUITING · sponsor: **The Affiliated Hospital of Qingdao University** · enrollment: 18 (estimated)

## Conditions studied

- Human Papillomavirus Associated Carcinomas
- Cervical Cancer
- Head and Neck Cancers
- Anal Cancer
- Vulva Cancer
- Vaginal Cancer
- Penile Cancer
- HPV-Related Malignancy

## Interventions

- **BIOLOGICAL:** SCG142 TCR-T cells

## Key facts

- **NCT ID:** NCT06544720
- **Lead sponsor:** The Affiliated Hospital of Qingdao University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-02
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06544720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06544720, "SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06544720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*